A Natural Plasmid Uniquely Encodes Two Biosynthetic Pathways Creating a Potent Anti-MRSA Antibiotic. by Fukuda, D et al.
 
 
A Natural Plasmid Uniquely Encodes Two
Biosynthetic Pathways Creating a Potent Anti-
MRSA Antibiotic.
Fukuda, D; Haines, Anthony; Song, Z; Murphy, AC; Hothersall, Joanne; Stephens, Elton;
Gurney, Rachel; Cox, RJ; Crosby, J; Willis, CL; Simpson, TJ; Thomas, Christopher
DOI:
10.1371/journal.pone.0018031
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Fukuda, D, Haines, A, Song, Z, Murphy, AC, Hothersall, J, Stephens, E, Gurney, R, Cox, RJ, Crosby, J, Willis,
CL, Simpson, TJ & Thomas, C 2011, 'A Natural Plasmid Uniquely Encodes Two Biosynthetic Pathways Creating
a Potent Anti-MRSA Antibiotic.', PLoS ONE, vol. 6, no. 3, pp. e18031.
https://doi.org/10.1371/journal.pone.0018031
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
A Natural Plasmid Uniquely Encodes Two Biosynthetic
Pathways Creating a Potent Anti-MRSA Antibiotic
Daisuke Fukuda1., Anthony S. Haines1., Zhongshu Song2, Annabel C. Murphy2, Joanne Hothersall1,
Elton R. Stephens1, Rachel Gurney1, Russell J. Cox2, John Crosby2, Christine L. Willis2, Thomas J.
Simpson2, Christopher M. Thomas1*
1 School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom, 2 School of Chemistry, University of Bristol, Cantock’s Close, Bristol, United Kingdom
Abstract
Background: Understanding how complex antibiotics are synthesised by their producer bacteria is essential for creation of
new families of bioactive compounds. Thiomarinols, produced by marine bacteria belonging to the genus
Pseudoalteromonas, are hybrids of two independently active species: the pseudomonic acid mixture, mupirocin, which
is used clinically against MRSA, and the pyrrothine core of holomycin.
Methodology/Principal Findings: High throughput DNA sequencing of the complete genome of the producer bacterium
revealed a novel 97 kb plasmid, pTML1, consisting almost entirely of two distinct gene clusters. Targeted gene knockouts
confirmed the role of these clusters in biosynthesis of the two separate components, pseudomonic acid and the pyrrothine,
and identified a putative amide synthetase that joins them together. Feeding mupirocin to a mutant unable to make the
endogenous pseudomonic acid created a novel hybrid with the pyrrothine via ‘‘mutasynthesis’’ that allows inhibition of
mupirocin-resistant isoleucyl-tRNA synthetase, the mupirocin target. A mutant defective in pyrrothine biosynthesis was also
able to incorporate alternative amine substrates.
Conclusions/Significance: Plasmid pTML1 provides a paradigm for combining independent antibiotic biosynthetic pathways or
using mutasynthesis to develop a new family of hybrid derivatives that may extend the effective use of mupirocin against MRSA.
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Introduction
The inexorable rise of antibiotic resistance in clinically
important bacteria makes it vital not only to identify new classes
of antimicrobial compounds but also to develop new derivatives of
existing compounds that can extend their effective use. Thiomar-
inols [1–4], produced by marine bacteria, form a novel family of
natural compounds with potent antimicrobial activity. They
consist of two components each related to independent antibiotics:
the clinically important anti-methicillin resistant Staphylococcus
aureus (MRSA) antibiotic mupirocin in which a polyketide moiety,
monic acid, is esterified by an unusual fatty acid component, 9-
hydroxynonanoic acid [5,6]; and a pyrrothine moiety, previously
found in the antibiotic holomycin [7] and related compounds. In
thiomarinol the pyrrothine is attached via an amide linkage to an
8-hydroxyoctanoic acid side-chain in the mupirocin-like compo-
nent, called marinolic acid by analogy with mupirocin’s more
generic name, pseudomonic acid (Figure 1).
The mupirocin biosynthetic (mup) gene cluster from the soil and
plant root-associated bacterium Pseudomonas fluorescens was sequenced
some time ago [5] and many of the key steps of the biosynthetic
pathways have been worked out over the last 10 years [6]. When this
project started the genes responsible for holomycin production by
the producer organism Streptomyces clavuligerus [8] were not known but
very recently the identification of the gene cluster and the analysis of
key steps in the pathway have been described [9]. Mupirocin is
particularly effective against Gram-positive bacteria [6] whereas
thiomarinols are also effective against many Gram-negative species
[1]. This increased potency may be due to: increased uptake, since
the outer membrane is thought to be a barrier that protects Gram-
negative bacteria; the targeting of more than one cellular function,
since the pyrrothine moiety in the form of holomycin and thiolutein
inhibits RNA synthesis [7] rather than protein synthesis which is the
ultimate target of mupirocin; or increased activity against the normal
target for mupirocin, isoleucyl-tRNA synthetase (IleS) [10].
The purpose of this work was to determine what mechanism brings
together the products of these two pathways and establish whether
this reveals a strategy for creating new hybrid molecules that may
have useful biological activities. The results reveal a novel plasmid
that is devoted almost entirely to carriage of these two biosynthetic
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pathways and indicate not only new mutasynthesis pathways but a
paradigm for generating new strains that combines the products of
different pathways and creates more potent bioactive molecules.
Results
The thiomarinol biosynthetic genes are encoded on a
plasmid
To identify the genes for thiomarinol biosynthesis we sequenced
total DNA from the producer organism, Pseudoalteromonas sp SANK
73390. One of the 273 contigs obtained (approximately 97 kb)
encoded many genes with similarity to those of the mup cluster
(Figure 2). As part of preliminary work we had used degenerate
primers, designed on the basis of conserved segments of the
mupirocin ketosynthase (KS) coding regions, to amplify putative
thiomarinol KS sequences as described in Materials and Methods.
This had yielded a number of products which were sequenced and
one of these which matched part of the largest polyketide (PKS)
gene (tmpD) was used for suicide mutagenesis using vector
pAKE604 [13]. Mutants showed reduced antibacterial activity
and LCMS analysis confirmed the loss of thiomarinol production,
but continued production of pyrrothine-containing compounds
(Figure 3).
Further analysis of this contig showed that it constitutes a
circular plasmid which we designate pTML1 (Figure 2). The
evidence for it being a circular plasmid is as follows. First, the
Figure 1. Chemical structures of A pseudomonic acid A (mupirocin) and B thiomarinol A. Holomycin is the amide N-acetylpyrrothine. In
addition to thiomarinol, producer-bacteria generate a variety of fatty acyl pyrrothine analogues. The new hybrids created consist of pseudomonic
acid A A with pyrrothine joined via an amide bond as in B to create the mupirocin pyrrothine amides C.
doi:10.1371/journal.pone.0018031.g001
A Plasmid Encoding Thiomarinol Biosynthesis
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e18031
initial annotation identified the 59 and 39 ends of the same gene at
opposite ends of the 97 kb contig and further analysis identified
reads across the apparent gap which is artificial, created by the fact
that the standard assembly software does not seek to create circles.
Furthermore, we also considered the remote possibility that the
single copy of the putative Insertion Sequence (IS) might actually
represent the insertion site of a larger segment (or segments of a
linear plasmid) flanked by identical copies of the same element. To
test this possibility we performed PCR with primers described in
Materials and Methods that hybridised to the unique sequences on
either side of the putative IS. A clean product of the expected size
(3822 bp) was observed, confirming the absence of an additional
segment. Second, one orf in this contig encodes a putative DNA
replication initiator (Rep) protein similar to that of the mega-
plasmid-like Chromosome II of Pseudoalteromonas haloplanktis
TAC125 [14] (CR945247: 635,328 bp) and two adjacent orfs
encode proteins similar to plasmid partitioning proteins from the
same source. Third, using sucrose selection against the pA-
KE604:tmpD suicide mutant (that is, sucrose sensitivity due to
levansucrase encoded by pAKE604) we could isolate white
colonies (indicating a loss of production of the yellow pigmented
pyrrothine moiety of thiomarinol) where loss of the whole element
was confirmed by multiple PCR reactions spread across the
plasmid including the rep gene. Thus pTML1 is not essential for
SANK 73390 to survive.
Thiomarinol biosynthesis depends on two independent
pathways
After finishing, the sequence of pTML1 is 97,600 bp with a
G+C content (43.2%), slightly higher than the average for all the
genomic DNA (40.6%) but contrasting with the P. fluorescens
mupirocin biosynthetic cluster (G+C=56%) [5]. Annotation
showed forty five orfs (Figure 2 and Table S1; Accession number
FN689524). Five orfs, occupying only 7.6 kb, were typical of
mobile DNA (replication, partitioning, transposition and integra-
tion) but showed no evidence of conjugative transfer functions.
Twenty seven orfs encode products expected for an essentially
complete mupirocin biosynthetic cluster producing marinolic acid
(Figure 1). The gene order for the type I polyketide synthase (PKS)
genes (tmpA to tmpD) is similar to the mup cluster [5] (Figure 4).
Minor differences in the functions present compared to the mup
cluster are an extra ACP in the third module of TmpD, an extra
ACP in the last module of TmpA and two extra ACPs in TmpB,
one in a group of four and one following an extra KS to create a
second module in this protein (Figures 2 and 4). Multiple ACPs in
the mupirocin cluster have been found to generally increase
pathway throughput rather than being essential [15] By contrast,
the tailoring genes are significantly rearranged (Figure 4) the whole
gene set being split into at least five transcriptional units
distinguished by direction of transcription and interruption by
the backbone functions of rep/par and transposition functions (tmlT
to tmlN, tmlM to tacpB, tmlA to tmlF, tmlY to tmlP and tacpA to holH;
Figure 2). Although the low G+C content of the DNA makes it
quite difficult to predict promoter sequences, closely related
inverted repeats are found in the spaces between the divergent
tmlM to tacpB/tmlA to tmlF and tmlY to tmlP and tacpA to holH units
and are likely candidates for operator sequences through which
the genes are regulated, although no obvious regulatory protein
was found in the plasmid.
The absence of mAcpE, implicated in the last steps of
pseudomonic acid production [16], but an extra module (KS
and ACP) in TmpB, suggests that all late tailoring steps may
happen on TmpB (Figure 5). There is a clear conservation of the
PKS and associated parts of the biosynthesis clusters for mupirocin
and thiomarinol (Figure 4). However, a high degree of sequence
divergence between the predicted products of each ORF (the level
of sequence identity varies from approximately 40% to 60%
identity in amino acid sequence alignments, although the identity
Figure 2. Map of pTML1 showing predicted protein-coding sequences drawn above or below the DNA line to indicate direction,
with predicted biosynthesis domains colour-coded as listed in the key. Modules can be identified by segments of megaproteins running
from a KS (red) to an ACP (green). Putative protein binding sites are shown as red and purple discs (in the replication origin, oriV) and green discs (‘IR’
for inverted repeat, associated with the biosynthetic cluster promoter regions and likely to be transcriptional regulator binding sites). Like the
mupirocin biosynthetic genes the thiomarinol synthases belong to the trans-AT synthases that encode a separate Acyl Transferase while linked to
each KS domain is an adjacent ‘‘docking domain’’ consisting of incomplete motifs from Acyl Transferases [11] that may facilitate or regulate acyl
transfer [12].
doi:10.1371/journal.pone.0018031.g002
A Plasmid Encoding Thiomarinol Biosynthesis
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Figure 3. HPLC analysis of products from wild type Pseudoalteromonas rava SANK 73390 and mutant derivatives. In the wild type the
majority of thiomarinol is present in the medium while significant levels of aliphatic pyrrothines are associated with the cells. The results show that: in
the KS2 mutant, only the acyl pyrrothines are produced; in the NRPS2 mutant only marinolic acid as produced; and that in the tmlU mutant, both
marinolic acid and acyl pyrrothines are produced by thiomarinol itself is not produced.
doi:10.1371/journal.pone.0018031.g003
Figure 4. Comparison of the organisation of the thiomarinol gene cluster (upper line) with the mupirocin biosynthesis gene cluster
from Pseudomonas fluorescens (lower line) and (boxed, on right) with related NRPS clusters from (top to bottom) Yersinia ruckeri
ATCC29473, Streptomyces clavuligerus ATCC27064 and Photorhabdus asymbiotica ATCC43949. Lines connecting orfs are simply to help
identify equivalent genes and do not indicate the degree of relatedness. A full map of pTML1 is shown in Figure 2. macpE (labelled ‘‘e’’), which is
critically missing from the thiomarinol cluster, lies between mmpF and mupT.
doi:10.1371/journal.pone.0018031.g004
A Plasmid Encoding Thiomarinol Biosynthesis
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is locally higher in functionally constrained regions, Table S1) is
observed. This raises intriguing questions about whether there will
be functional cross-complementation between the pathways, an
issue that will be investigated in a future publication.
A particularly exciting feature of the gene cluster was a group of
seven orfs with similarities to several putative non-ribosomal
peptide synthetase (NRPS) gene clusters which until very recently
had no assigned product(s). These include clusters from Streptomyces
clavuligerus (genome sequence of strain ATCC 27064, accession
numbers EDY50341 and ADWJ01000000 [17]) that makes
holomycin [7–9] and Photorabdus assymbiotica [18] and Yersinia
ruckeri ATTC43949 [19] that synthesize related compounds [20]
(Figure 4). We therefore designated these genes holA (NRPS), holB
(oxidoreductase), holC [thiolesterase), holD (dehydrogenase), holE
(acyltransferase), holF (oxygenase), and holG (decarboxylase).
Functional analysis of the homologous genes from S. clavuligerus
has recently been reported, confirming their roles but leaving
significant questions [9]. For example, the encoded NRPS (HolA),
which possesses active site amino acids consistent with selectivity
for cysteine [21], encodes only single adenylation, thiolation
(peptidyl carrier protein, PCP), and condensation domains while a
dipeptide would formally require two adenylation and two PCP
domains. Since the pyrrothine should start with formation of a
cysteinyl-cysteine dipeptide, HolA may be an iterative NRPS as in
siderophore biosynthesis [22] and could possibly work as a dimer.
The function of HolH, which does not have a counterpart in the
related clusters, is not known. An overview of the predicted
pTML1 thiomarinol biosynthetic pathway is shown in Figure 5.
To confirm the identity of the genes encoding pyrrothine
production an internal segment of holA was used for suicide
mutagenesis, producing mutants lacking yellow pigment. LCMS of
WT bacteria showed thiomarinol A (m/z 640 Da) in both whole
cells and supernatant whereas the holA (NRPS) mutant produced
only marinolic acid (m/z 486 Da). Similarly the tmpD (PKS)
mutant produced only yellow pigmented pyrrothine material
(Figure 3). This confirms that marinolic acid and the pyrrothine
can be made separately. TmlU shows similarity to SimL (Figure
S1) that creates an amide linkage during biosynthesis of the
antibiotic simocylinone [23,24] as well as NovL which plays a
similar role in novobiocin biosynthesis [25]. A mutant with an in-
frame deletion in tmlU made both marinolic acid and pyrrothines
but no thiomarinol (Figure 3) strongly suggesting a role for TmlU
in joining them together.
Mutants defective in one or other pathway can use
exogenous substrates
To test for cosynthesis we co-fermented the DtmpD and DholA
mutants. LCMS analysis confirmed that production of thiomarinol
was restored. Addition of marinolic acid to the DtmpD mutant also
restored thiomarinol production. Furthermore, addition of pseudo-
monic acid A to the DtmpDmutant gave rise to two novel pyrrothine
amides (Figure 1c) indicating that mutasynthesis is possible. Feeding
with a range of alternative substrates reported fully elsewhere [26]
showed that alternative pseudomonic acid metabolites produced by
P. fluorescens or amines (for example anhydroornithine) could be
incorporated by DtmpD and DholA mutants respectively confirming
the potential to create new families of hybrids.
Thiomarinol can overcome mupirocin resistance
Plasmid-free segregants of SANK 73390 were sensitive to
thiomarinol confirming that resistance requires pTML1. The tmlM
Figure 5. Predicted biosynthetic scheme for thiomarinol biosynthesis showing the roles of TmpD (modules 1 to 4)/TmpA (modules
5 and 6) for monic acid, TmpB for 8-hydroxyoctanoic acid and HolA/NRPS for pyrrothine. A detailed scheme for biosynthesis of the
pyrrothine can be found in ref [9]. Individual functions in multifunctional proteins are shown by the colour-coded blocks: KS, Ketosynthase; ACP, Acyl
Carrier Protein; KR, Ketoreductase; DH, Dehydratase; ER, Enoyl Reductase; MT, Methyl Transferase; TE, Thioesterase; C, Condensation; A, Aminoacyl
Adenylation Domain; T, Thiolation Domain or Peptidyl Carrier Protein.
doi:10.1371/journal.pone.0018031.g005
A Plasmid Encoding Thiomarinol Biosynthesis
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gene encodes a putative isoleucyl tRNA synthetase related to
MupM that prevents suicide in the mupirocin producer [5,27] but
no additional gene(s) conferring resistance to the pyrrothine
element was identified. Expression of mupM and tmlM in E. coli
under the control of the tac promoter and determination of
thiomarinol resistance (by both plate bioassay and minimal
inhibitory concentration, MIC, determination) with appropriate
controls showed that mupM confers slight resistance to thiomarinol
(MIC=1 mg ml21 compared to 0.5 mg ml21 for the empty vector)
while tmlM confers high level resistance (MIC$16 mg ml21),
suggesting that thiomarinol targets only isoleucyl tRNA synthetase.
Thiomarinol was therefore tested for its ability to inhibit growth of
methicillin resistant Staphylococcus aureus (MRSA) that had acquired
high level resistance to mupirocin. A plate bioassay showed that
clearly thiomarinol could inhibit growth of this strain although the
clearing zone was considerably smaller than with the mupirocin
sensitive strain (Figure 6). We checked by PCR that this strain
carries the S.aureus mupA gene, that encodes an isoleucyl tRNA
synthetase conferring high level mupirocin resistance, and then
cloned and expressed it in E. coli from a context identical to that
for mupM and tmlM. It also conferred resistance to mupirocin in E.
coli (MIC=50 mg ml21) and gave partial resistance to thiomarinol
(MIC=2 to 4 mg ml21) slightly higher than that for the mupM gene
but was clearly inhibited at concentrations that were not inhibitory
for bacteria carrying tmlM. Thus essentially complete resistance to
thiomarinol can be conferred by an altered ileS gene (tmlM) while
the mupirocin resistant ileS genes (mupM and mupA) only confer
partial resistance.
Biological activities of a selection of the new compounds
identified in this work [26] were compared by plate bioassay and
minimum inhibitory concentration in liquid culture with E. coli
and S. aureus (MRSA) as indicator strains. Both thiomarinol and
the novel mupirocin pyrrothine amides created by feeding
mupirocin as the standard mixture of pseudomonic acids,
inhibited growth of both species although S. aureus was more
sensitive (MIC#30 ng ml21 compared to 0.5 mg ml21). Marinolic
acid inhibited S. aureus (MIC=1 mg ml21) but less well than
mupirocin (MIC=0.125 mg ml21) confirming that the added
pyrrothine is responsible for the increased potency of thiomarinol.
Individual fatty acylpyrrothines isolated from Pseudoalteromonas sp
SANK 73390 had no activity against E. coli and only weak activity
against S. aureus[26]. Against MRSA carrying mupA, only the
pyrrothine amides were active and thiomarinol (MIC=8 mg ml21)
was slightly more active than the mupirocin pyrrothine amide
(MIC=16–32 mg ml21). The partial resistance of mupirocin-
resistant MRSA to thiomarinol is consistent with the partial
resistance that mupA confers to thiomarinol in E. coli.
Discussion
Although a variety of mechanisms allow plasmid-bearing
bacteria to kill their neighbours [28] pTML1 uniquely dedicates
essentially all of its large genome to making a single family of
hybrid molecules which have potent antibiotic activity against both
Gram-positive and Gram-negative bacteria. It may thus function
as a way of providing an advantage for bacteria carrying the
plasmid but the density of plasmid positive bacteria required to
achieve this effect is not yet known. Antibiotic biosynthesis clusters
on other plasmids are generally found as just one of a number of
functions. The genes for methylenomycin occupy only about
20 kb on the 356 kb megaplasmid SCP1 in Streptomyces coelicolor A3
[29] while production of tropodithietic acid occupies about 10 kb
on plasmids ranging from 60 to 130 kb in marine Roseobacter
species [30]. The 211 kb plasmid pSLA2-L from Streptomyces rochei
carries two antibiotic clusters, for lankamycin and lankacidin,
among four secondary metabolite gene clusters which occupy 75%
of the plasmid [31]. More recently a 1.8 Mb linear plasmid from
Streptomyces clavuligerus was found to carry numerous secondary
metabolite biosynthetic clusters [32]. A plasmid location might
promote spread of these genes between hosts but surprisingly there
is no evidence of conjugative transfer genes in pTML1. It is also
surprising that, although there are putative operator sequences
(inverted repeats shown in green, Figure 2) in the divergent
promoter regions, there are no obvious candidates for regulatory
proteins in the plasmid (Table S1) suggesting that regulation may
be dependent on chromosomal genes and posing a potential
problem for the plasmid if it were to transfer to a host that was not
able to provide this function. This is doubly surprising since the
mupirocin genes in P. fluoresens have their own quorum regulation
cassette [13]. While these gene sets appear to have been acquired
from different ancestors neither the average G+C content of the
two gene sets nor the codon usage give any indication of this,
suggesting that the genes have evolved together for some
considerable time.
Our results confirm the hypothesis that both components of
thiomarinol, the pseudomonic acids similar to mupirocin and the
pyrrothine similar to holomycin, are synthesised by gene sets
related to those that synthesise these molecules from organisms
that make them independently [5,9]. Detailed comparison of the
pseudomonic acid and marinolic acid biosynthesis genes reveals a
number of interesting features apart from the obvious rearrange-
ment of gene order (Figure 2).
First, there is no evidence for regulatory genes as part of the
thiomarinol gene cluster and the putative operators in likely
promoter regions do not show obvious similarity to the Lux boxes
found in the mup cluster [13,33] so we can not make any
predictions about mechanism, if any, by which expression is
regulated.
Second, alignments of TmlA not only identify MupA but also
OnnC and PedJ proteins from the onnamide and pederin
pathways in which they are proposed to introduce hydroxyl
Figure 6. Bioassay comparing the effects of thiomarinol and
mupirocin against Methicillin Resistant Staphylococcus aureus
(MRSA) and High level Mupirocin Resistant MRSA. The loaded
amount of thiomarinol was calculated as 25 mg, and same amount of
PA-A was spotted onto the paper disc ‘‘M’’.
doi:10.1371/journal.pone.0018031.g006
A Plasmid Encoding Thiomarinol Biosynthesis
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groups at C7 [34,35]. Since the location of mupA/tmlA immediately
upstream of mmpA/tmpA is conserved in both clusters we
hypothesise that it is responsible for the C6 hydroxylation of
monic acid and that this occurs while it is attached to the non-
elongating module at the start of MmpA/TmpA [5].
Third, the hydroxymethylglutarate CoA synthase (HCS)
cassette which is responsible for insertion of the C15 methyl
group [36] lacks an independent gene encoding an homologue of
MupK, the second hydratase (responsible for decarboxylation, the
last step in the pathway), although this function seems likely to be
provided by TmpE whose N-terminus aligns with MupK. In the
mup cluster mupK and mmpE lie one after the other so a simple gene
fusion could be responsible for this arrangement. However, in the
kalamanticin/batumin cluster the Type I PKS Bat3 has a similar
conjunction of a hydratase followed by a KS at the junction of
modules 9 and 10 as part of a much larger type I PKS protein
[37]. Significantly, this is where the second of four methyl
insertions by the HCS cassette occurs. However, since the
sequence identities with MupK (60%) and BatE (57%), its
equivalent in the kalamanticin/batumin cluster, are higher than
with the hydratase segment in Bat3 it seems more likely to have
arisen by the proposed fusion than direct descent as a fused protein
from a common ancestor with Bat3. An additional inference from
this fusion, based on the assumption that most parts of the
biosynthetic factory are tethered in an orderly assembly, is that the
action of the KS and any additional functions of TmpE may
normally be performed at the same stage of biosynthesis that the
HCS cassette works (i.e. at completion of the monic acid
backbone).
Fourth, the only gene in the mup cluster that does not have an
equivalent in the thiomarinol biosynthetic cluster is macpE, that is
essential for pseudomonic acid A production but not pseudomonic
acid B [16]. In the mup cluster we have proposed that MupU is
responsible for transferring an intermediate to mAcpE where it is
processed by MupO,V,C and F [33]. However, TmpB has an
extra KS and ACP that MmpB does not have, while TmlU clearly
has a role that is different from, or additional to, the role of MupU
in transferring an intermediate to mAcpE suggesting the possibility
that the final processing to produce thiomarinol happens on
TmpB before release by the action of the TmpB TE. This could
mean that there is less potential for leakiness (release before
completion of all biosynthetic steps) at this stage of biosynthesis
which might explain why thiomarinol G, the equivalent of
pseudomonic acid B (hydroxylated at C9; Figure 1), is hardly
detectable (AM, unpublished). Work to test this hypothesis is
underway.
The identification of a single thiomarinol resistance gene,
tmlM, encoded on pTML1 and the finding that this gene is
sufficient to confer high level (essentially complete) thiomarinol
resistance indicated that the enhanced activity of thiomarinol
compared to mupirocin is most likely due to an increased ability
to bind to and inhibit isoleucyl tRNA synthetase rather than
activity against a second target. This also indicates that the ability
of thiomarinol to inhibit the growth of bacteria carrying the
mupirocin resistant isoleucyl tRNA synthetases encoded by
either mupM from the P. fluorescens mupirocin-producer strain
NCIMB10586 or mupA from S. aureus is likely to be due to this
increased potency against these IleS enzymes rather than the
inhibition of a second target. This is also consistent with the
finding that the potency of thiomarinol is destroyed by hydrolysis
of the amide bond which indicates that the molecule must remain
intact to exert its effect. An alternative explanation, that the
hybrid is hydrolysed to its component parts after entry and that
these work separately, is not consistent with the data. The results
therefore provide justification for exploration of alternative
additions to the carboxylic acid end of pseudomonic acid in
order to identify ways to overcome mupirocin resistant enzymes.
Interestingly, MupM is not the closest relative of TmlM, there
being many other homologues from other prokaryotes as well as
from higher eukaryotes that are much closer in sequence.
Whether this indicates selective pressure or horizontal gene
transfer and recombination is not clear.
This is the first documented example of independent pathways
to known antibiotics combining to create a hybrid, although
antibiotics simocyclinone [38] and onnamide [35] are built from
sub-pathways. Our data show that the added pyrrothine increases
potency of marinolic/pseudomonic acid against isoleucyl tRNA
synthetase, overcoming resistance to mupirocin in contrast to
chemical modifications explored previously [39]. We identified a
gene tmlU that is required for formation of the amide. The product
of this gene belongs to a growing family of amide synthases [22–
24] that provide important potential for creating diverse hybrid
molecules [40]. It may allow second site interactions that
strengthen binding as proposed for simocylinone with DNA
gyrase[41]. In combination with the crystal structure of isoleucyl
tRNA synthetase with mupirocin [42] our data provide the basis
for generating new families of compounds that may be useful
against MRSA.
Materials and Methods
Pseudoalteromonas sp SANK 73390 and E. coli strains was grown
on Marine broth/agar [1] at 23uC, Escherichia coli DH5a and S17-
1 were grown on L Broth or L agar at 37uC [43] and Staphylococcus
aureus NCTC 12493 and 16HLmupR1 were grown on Mueller
Hinton II broth/agar at 37uC. Cloning vector pGEM-T (www.
promega.com) and suicide plasmid pAKE604 [13] were described
previously.
Genomic and plasmid DNA isolation, manipulation, transfor-
mation and analysis were carried out by standard procedures [43].
The genome sequencing was performed at the Liverpool
Microarray Facility at University of Liverpool using a 454
Titanium FLX kit and hardware. Automated assembly into
contigs was achieved using 454 Newbler assembler software and
finishing was directed by Phred/Phrap/Consed software, PCR
with primers from Sigma and sequencing in the University of
Birmingham Genomics lab using an ABI 3700 capillary
sequencer. Sequence analysis and annotation used Artemis/ACT
software as well as http://www.nii.res.in/nrps-pks.html which are
specific for PKS/Non Ribosomal Peptide Synthetase functions. To
confirm that the putative IS element is a single copy and does not
represent a segment flanked by two copies PCR was performed
with primers that hybridise in the unique segments on either side
(59 –TCCCTTGTGCTAGTGTCATAG -39 and 59-AGGCTT-
GAGTCAGATTAAGTCT-39).
Gene knockouts were performed as described previously using
suicide plasmid pAKE604 [13] into which we cloned selected
segments from the target genes, mobilising to SANK 73390 via E.
coli strain S17-1. For the KS (tmpD) knockout a 1 kb segment
corresponding to position 5182 to 6158 in tmpD (KS-D2) which
had been amplified with degenerate primers (59 - ATGGAYCCB-
CAGSARCGYYTGTT -39 and 59 - TTYGGBKYCGGCGG-
KRCSAAYGC -39) was used. For the NRPS knockout a 480 bp
segment corresponding to positions 1509 to 1990 using specific
primers (59- CCAGAATTCGATGCAAATGCTAGGCT -39
incorporating a EcoRI site and 59- AGCTAAAGCTTC-
TAGTTCTGCAACTC -39 incorporating a HindIII site) was
used. For the tmlU knockout an in-frame deletion was created by
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using PCR to generate upstream (59- TTTAGTCTAGATAG-
GCGCAACCTT G -39 incorporating an XbaI site and 59-
CGGGAAAACGCTGCAGAAATGGATG -39 incorporating a
PstI site) and downstream (59- CGTTTACTGCAGTGCTCG-
CTGAGC -39 incorporating a PstI site and 59- ATAGCCC-
TGTCGACCGTACCCAA -39 incorporating a SalI site) arms
that were joined via the common PstI site and cloned into
pAKE604.
Antibiotic plate bioassay was performed as described previously
[5]. Expression constructs for mupM, tmlM and mupA (from S. aureus)
were constructed based on tac promoter expression vector pJH10
[5]. In addition, thiomarinol was extracted from 2 day cultures of
SANK 73390 and dried onto filter paper discs that were placed on
bacterial lawns. HPLC and mass spectrometric analysis of bacterial
products were performed as described elsewhere [44].
Supporting Information
Figure S1 Alignment of the amino acid sequences of
TmlU, SimL (AAG34183) and NovL (AAF67505).
(TIF)
Table S1 Predicted gene products of pTML1.
(DOC)
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